| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |